Oppenheimer reiterated their outperform rating on shares of Zimmer Biomet (NYSE:ZBH – Free Report) in a report published on Wednesday morning, Benzinga reports. Oppenheimer currently has a $157.00 price target on the medical equipment provider’s stock. Several other research firms have also recently weighed in on ZBH. JMP Securities reissued a market outperform rating and […]
Moors & Cabot Inc. lessened its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 5.0% during the first quarter, Holdings Channel.com reports. The fund owned 2,592 shares of the medical equipment provider’s stock after selling 136 shares during the period. Moors & Cabot Inc.’s holdings in Zimmer Biomet were worth $335,000 at […]
Morgan Stanley reaffirmed their equal weight rating on shares of Zimmer Biomet (NYSE:ZBH – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a $140.00 price objective on the medical equipment provider’s stock. A number of other research firms have also weighed in on ZBH. SpectralCast reissued […]
Costello Asset Management INC grew its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 24.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,147 shares of the medical equipment provider’s stock after purchasing an additional 8,171 shares during the […]
Medtech companies should be thriving, providing surgical devices for an aging population. Instead, investors might think the rise of weight-loss drugs will.